I'm not sure it's quite that simple and my impression is the FDA is still to land on what's required for DMOAD status.
The thought leaders appear to have identified preferred surrogate SF biomarkers
Any thoughts on why they didn't previous disclosure "insufficient numbers of results above LLQ" for CTX-II, C2C, IL-1B and whether this then could impact 6 month results?
- Forums
- ASX - By Stock
- PAR
- MOZZ OARSI 2023 - NOTES
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.44%
!
42.0¢

MOZZ OARSI 2023 - NOTES, page-22
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
0.010(2.44%) |
Mkt cap ! $166.9M |
Open | High | Low | Value | Volume |
40.0¢ | 42.0¢ | 40.0¢ | $168.2K | 411.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 50665 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 0.410 |
1 | 1235 | 0.405 |
5 | 66500 | 0.400 |
4 | 67519 | 0.395 |
5 | 56650 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 50665 | 2 |
0.425 | 2860 | 1 |
0.430 | 28500 | 1 |
0.440 | 45000 | 2 |
0.445 | 1400 | 1 |
Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |